Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Launched by STANFORD UNIVERSITY · May 12, 2017
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
PRIMARY OBJECTIVES:
I. To reduce acute care utilization by 2-5% for advanced cancer patients by training and deploying health care coaches who help patients and families discuss care goals, virtual modalities, engage in shared-decision-making, and participate in educational activities.
SECONDARY OBJECTIVES:
I. To improve patients' experience of their care. II. Improve patient understanding of advanced care planning. III. To improve the receipt of goal concordant care. IV. To reduce total healthcare costs.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients receive usual ca...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newly diagnosed patients for the following conditions
- • Colon cancer stage III and IV
- • Rectal cancer stage II, III, IV
- • Glioblastoma multiforme (brain) -- no stage
- • Non-small cell lung cancer stage IIIA, IIIB, IV
- • Small cell lung cancer, limited stage and extensive stage
- • Castration-resistant prostate cancer
- • Head and neck cancer stage III and IV
- • Gastric cancer stage III and IV
- • Esophageal cancer stage III and IV
- • Pancreatic cancer stage II, III, IV
- • Renal cell carcinoma, stage IV
- • Breast cancer, stage IV, if triple negative ER/PR/H2N negative or on systemic chemotherapy
- • Sarcoma, stage IV
- • Bladder carcinoma, stage IV
- • Acute myeloid leukemia
- • Melanoma, stage III and IV
- • Ovarian cancer, stage III and IV
- • High grade myelodysplastic syndrome (MDS)
- • Any patient with recurrent or progressive cancer
- • Patients must have the ability to understand and willingness to sign a written informed consent document
- • Patient must have ongoing oncologic needs and plan to receive all care at the study institution and not already be in hospice or home-care
- Exclusion Criteria:
- • Patients must have capacity to consent
- • Pregnant patients are excluded
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fullerton, California, United States
Patients applied
Trial Officials
Manali Patel
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials